<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34511133</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>20</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1755-8794</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>11</Day></PubDate></JournalIssue><Title>BMC medical genomics</Title><ISOAbbreviation>BMC Med Genomics</ISOAbbreviation></Journal><ArticleTitle>Sequencing of neurofilament genes identified NEFH Ser787Arg as a novel risk variant of sporadic amyotrophic lateral sclerosis in Chinese subjects.</ArticleTitle><Pagination><StartPage>222</StartPage><MedlinePgn>222</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">222</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12920-021-01073-z</ELocationID><Abstract><AbstractText Label="BACKGROUND">Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease with neuronal cell inclusions composed of neurofilaments and other abnormal aggregative proteins as pathological hallmarks. Approximately 90% of patients have sporadic cases (sALS), and at least 4 genes, i.e. C9orf72, SOD1, FUS and TARDBP, have been identified as the main causative genes, while many others have been proposed as potential risk genes. However, these mutations could explain only ~&#x2009;10% of sALS cases. The neurofilament polypeptides encoded by NEFH, NEFM, and NEFL are promising protein biomarkers for ALS and other degenerative diseases. However, whether the genetic variants of these genes were associated with ALS remain ambiguous.</AbstractText><AbstractText Label="METHODS">Here, we used PCR-Sanger to sequence the exons of these three genes in a cohort of 371 sALS patients and 711 healthy controls (Phase I) and validated the risk variant in another 300 sALS patients and 1076 controls (Phase II).</AbstractText><AbstractText Label="RESULTS">A total of 92 variants were identified, including 36 rare heterozygous variants in NEFH, 27 in NEFM, and 16 in NEFL, and only rs568759161 (p.Ser787Arg) in NEFH reached nominal statistical power (P&#x2009;=&#x2009;0.02 at Phase I, P&#x2009;=&#x2009;0.009 at Phase II) in the case-control comparison. Together, the Phase I and II studies showed the significantly higher frequency of the variant in cases (9/1342, 0.67%) than in controls (2/3574, 0.07%) (OR 12.06; 95% CI 2.60-55.88; P&#x2009;=&#x2009;0.0003). No variants passed multiple testing in the discovery cohort, but rs568759161 was associated with ALS in a replication cohort.</AbstractText><AbstractText Label="CONCLUSIONS">Our results confirmed that NEFH Ser787Arg is a novel sALS risk variant in Chinese subjects, but NEFM and NEFL were not associated with sALS. These data may have implications for genetic counselling and for understanding the pathogenesis of sALS.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Feng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology, Fujian Medical University Union Hospital, Fujian, 350001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Wanhui</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, Fujian Medical University Union Hospital, Fujian, 350001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Chaofeng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Fujian Medical University Union Hospital, Fujian, 350001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Jilan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Fujian Medical University Union Hospital, Fujian, 350001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Junge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, 100053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xu-Ying</ForeName><Initials>XY</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, 100053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhanjun</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, 100053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chaodong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, 100053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Huapin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Fujian Medical University Union Hospital, Fujian, 350001, China. hh-p@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med Genomics</MedlineTA><NlmUniqueID>101319628</NlmUniqueID><ISSNLinking>1755-8794</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C531617">Amyotrophic lateral sclerosis 1</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Association</Keyword><Keyword MajorTopicYN="N">Neurofilament genes</Keyword><Keyword MajorTopicYN="N">Rare variant</Keyword><Keyword MajorTopicYN="N">Sporadic amyotrophic lateral sclerosis</Keyword></KeywordList><CoiStatement>None of the authors declared conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>13</Day><Hour>5</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34511133</ArticleId><ArticleId IdType="pmc">PMC8436554</ArticleId><ArticleId IdType="doi">10.1186/s12920-021-01073-z</ArticleId><ArticleId IdType="pii">10.1186/s12920-021-01073-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Leung CL, He CZ, Kaufmann P, Chin SS, Naini A, Liem RK, et al. A pathogenic peripherin gene mutation in a patient with amyotrophic lateral sclerosis. Brain Pathol. 2004;14:290&#x2013;296. doi: 10.1111/j.1750-3639.2004.tb00066.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-3639.2004.tb00066.x</ArticleId><ArticleId IdType="pmc">PMC8095763</ArticleId><ArticleId IdType="pubmed">15446584</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlary L, Plotkin SS, Yerbury JJ, Cashman NR. Prion-like propagation of protein misfolding and aggregation in amyotrophic lateral sclerosis. Front Mol Neurosci. 2019;12:262. doi: 10.3389/fnmol.2019.00262.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00262</ArticleId><ArticleId IdType="pmc">PMC6838634</ArticleId><ArticleId IdType="pubmed">31736708</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin H, Schlaepfer WW. Role of neurofilament aggregation in motor neuron disease. Ann Neurol. 2006;60:399&#x2013;406. doi: 10.1002/ana.20965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20965</ArticleId><ArticleId IdType="pubmed">17006927</ArticleId></ArticleIdList></Reference><Reference><Citation>Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol. 2019;32:771&#x2013;776. doi: 10.1097/WCO.0000000000000730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000730</ArticleId><ArticleId IdType="pmc">PMC6735526</ArticleId><ArticleId IdType="pubmed">31361627</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S, Zhou Y, Qian S, Chang W, Wang L, Fan D. Amyotrophic lateral sclerosis in Beijing: epidemiologic features and prognosis from 2010 to 2015. Brain Behav. 2018;8:e01131. doi: 10.1002/brb3.1131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.1131</ArticleId><ArticleId IdType="pmc">PMC6236245</ArticleId><ArticleId IdType="pubmed">30338660</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH, Jr, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17085. doi: 10.1038/nrdp.2017.85.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.85</ArticleId><ArticleId IdType="pubmed">29052611</ArticleId></ArticleIdList></Reference><Reference><Citation>Pampalakis G, Mitropoulos K, Xiromerisiou G, Dardiotis E, Deretzi G, Anagnostouli M, Katsila T, Rentzos M, Patrinos GP. New molecular diagnostic trends and biomarkers for amyotrophic lateral sclerosis. Hum Mutat. 2019;40(4):361&#x2013;373. doi: 10.1002/humu.23697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.23697</ArticleId><ArticleId IdType="pubmed">30556231</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentil BJ, Tibshirani M, Durham HD. Neurofilament dynamics and involvement in neurological disorders. Cell Tissue Res. 2015;360:609&#x2013;620. doi: 10.1007/s00441-014-2082-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-014-2082-7</ArticleId><ArticleId IdType="pubmed">25567110</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Miller CC. Neurofilaments and neurological disease. BioEssays. 2003;25:346&#x2013;355. doi: 10.1002/bies.10251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.10251</ArticleId><ArticleId IdType="pubmed">12655642</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayakawa Y, Sakumi K, Kajitani K, Kadoya T, Horie H, Kira J, et al. Galectin-1 deficiency improves axonal swelling of motor neurones in SOD1(G93A) transgenic mice. Neuropathol Appl Neurobiol. 2015;41:227&#x2013;244. doi: 10.1111/nan.12123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12123</ArticleId><ArticleId IdType="pubmed">24707896</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano A, Donnenfeld H, Sasaki S, Nakano I. Fine structural observations of neurofilamentous changes in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 1984;43:461&#x2013;470. doi: 10.1097/00005072-198409000-00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-198409000-00001</ArticleId><ArticleId IdType="pubmed">6540799</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano A, Nakano I, Kurland LT, Mulder DW, Holley PW, Saccomanno G. Fine structural study of neurofibrillary changes in a family with amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 1984;43:471&#x2013;480. doi: 10.1097/00005072-198409000-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-198409000-00002</ArticleId><ArticleId IdType="pubmed">6540800</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S, Maruyama S, Yamane K, Sakuma H, Takeishi M. Swellings of proximal axons in a case of motor neuron disease. Ann Neurol. 1989;25:520&#x2013;522. doi: 10.1002/ana.410250520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410250520</ArticleId><ArticleId IdType="pubmed">2774495</ArticleId></ArticleIdList></Reference><Reference><Citation>Elder GA, Friedrich VL, Jr, Pereira D, Tu PH, Zhang B, et al. Mice with disrupted midsized and heavy neurofilament genes lack axonal neurofilaments but have unaltered numbers of axonal microtubules. J Neurosci Res. 1999;57:23&#x2013;32. doi: 10.1002/(SICI)1097-4547(19990701)57:1&lt;23::AID-JNR3&gt;3.0.CO;2-A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4547(19990701)57:1&lt;23::AID-JNR3&gt;3.0.CO;2-A</ArticleId><ArticleId IdType="pubmed">10397632</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Xie F, Siedlak SL, Nunomura A, Honda K, Moreira PI, et al. Neurofilament proteins in neurodegenerative diseases. Cell Mol Life Sci. 2004;61:3057&#x2013;3075. doi: 10.1007/s00018-004-4268-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-004-4268-8</ArticleId><ArticleId IdType="pubmed">15583867</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge WW, Leystra-Lantz C, Wen W, Strong MJ. Selective loss of trans-acting instability determinants of neurofilament mRNA in amyotrophic lateral sclerosis spinal cord. J Biol Chem. 2003;278:26558&#x2013;26563. doi: 10.1074/jbc.M302886200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M302886200</ArticleId><ArticleId IdType="pubmed">12730211</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergeron C, Beric-Maskarel K, Muntasser S, Weyer L, Somerville MJ, Percy ME. Neurofilament light and polyadenylated mRNA levels are decreased in amyotrophic lateral sclerosis motor neurons. J Neuropathol Exp Neurol. 1994;53:221&#x2013;230. doi: 10.1097/00005072-199405000-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-199405000-00002</ArticleId><ArticleId IdType="pubmed">7909836</ArticleId></ArticleIdList></Reference><Reference><Citation>Poesen K, Van Damme P. Diagnostic and prognostic performance of neurofilaments in ALS. Front Neurol. 2018;9:1167. doi: 10.3389/fneur.2018.01167.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.01167</ArticleId><ArticleId IdType="pmc">PMC6345692</ArticleId><ArticleId IdType="pubmed">30713520</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil M, Teunissen CE, Otto M, Piehl F, Sormani MP, Gattringer T, et al. Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol. 2018;14:577&#x2013;589. doi: 10.1038/s41582-018-0058-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0058-z</ArticleId><ArticleId IdType="pubmed">30171200</ArticleId></ArticleIdList></Reference><Reference><Citation>Oeckl P, Jardel C, Salachas F, Lamari F, Andersen PM, Bowser R, et al. Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:404&#x2013;413. doi: 10.3109/21678421.2016.1167913.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2016.1167913</ArticleId><ArticleId IdType="pubmed">27415180</ArticleId></ArticleIdList></Reference><Reference><Citation>Figlewicz DA, Krizus A, Martinoli MG, Meininger V, Dib M, Rouleau GA, et al. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum Mol Genet. 1994;3:1757&#x2013;1761. doi: 10.1093/hmg/3.10.1757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/3.10.1757</ArticleId><ArticleId IdType="pubmed">7849698</ArticleId></ArticleIdList></Reference><Reference><Citation>Skvortsova V, Shadrina M, Slominsky P, Levitsky G, Kondratieva E, Zherebtsova A, et al. Analysis of heavy neurofilament subunit gene polymorphism in Russian patients with sporadic motor neuron disease (MND) Eur J Hum Genet. 2004;12:241&#x2013;244. doi: 10.1038/sj.ejhg.5201144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ejhg.5201144</ArticleId><ArticleId IdType="pubmed">14722583</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Andersen PM, Nilsson P, Chioza B, Andersson JL, Russ C, et al. Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum Mol Genet. 1999;8:157&#x2013;164. doi: 10.1093/hmg/8.2.157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/8.2.157</ArticleId><ArticleId IdType="pubmed">9931323</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripolszki K, Gampawar P, Schmidt H, Nagy ZF, Nagy D, Kliv&#xe9;nyi P, et al. Comprehensive genetic analysis of a Hungarian amyotrophic lateral sclerosis cohort. Front Genet. 2019;10:732. doi: 10.3389/fgene.2019.00732.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2019.00732</ArticleId><ArticleId IdType="pmc">PMC6707335</ArticleId><ArticleId IdType="pubmed">31475037</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomkins J, Usher P, Slade JY, Ince PG, Curtis A, Bushby K, et al. Novel insertion in the KSP region of the neurofilament heavy gene in amyotrophic lateral sclerosis (ALS) NeuroReport. 1998;9:3967&#x2013;3970. doi: 10.1097/00001756-199812010-00036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-199812010-00036</ArticleId><ArticleId IdType="pubmed">9875737</ArticleId></ArticleIdList></Reference><Reference><Citation>Vechio JD, Bruijn LI, Xu Z, Brown RH, Jr, Cleveland DW. Sequence variants in human neurofilament proteins: absence of linkage to familial amyotrophic lateral sclerosis. Ann Neurol. 1996;40:603&#x2013;610. doi: 10.1002/ana.410400410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410400410</ArticleId><ArticleId IdType="pubmed">8871580</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooke K, Figlewicz DA, Han FY, Rouleau GA. Analysis of the KSP repeat of the neurofilament heavy subunit in familiar amyotrophic lateral sclerosis. Neurology. 1996;46:789&#x2013;790. doi: 10.1212/WNL.46.3.789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.46.3.789</ArticleId><ArticleId IdType="pubmed">8618684</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia ML, Singleton AB, Hernandez D, Ward CM, Evey C, Sapp PA, et al. Mutations in neurofilament genes are not a significant primary cause of non-SOD1-mediated amyotrophic lateral sclerosis. Neurobiol Dis. 2006;21:102&#x2013;109. doi: 10.1016/j.nbd.2005.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2005.06.016</ArticleId><ArticleId IdType="pubmed">16084104</ArticleId></ArticleIdList></Reference><Reference><Citation>Julien JP. Amyotrophic lateral sclerosis. Unfolding the toxicity of the misfolded. Cell. 2001;104:581&#x2013;591. doi: 10.1016/S0092-8674(01)00244-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(01)00244-6</ArticleId><ArticleId IdType="pubmed">11239414</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu YY, Kuo HC. Functional roles and networks of non-coding RNAs in the pathogenesis of neurodegenerative diseases. J Biomed Sci. 2020;27:49. doi: 10.1186/s12929-020-00636-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-020-00636-z</ArticleId><ArticleId IdType="pmc">PMC7140545</ArticleId><ArticleId IdType="pubmed">32264890</ArticleId></ArticleIdList></Reference><Reference><Citation>Bomont P, Cavalier L, Blondeau F, Ben Hamida C, Belal S, Tazir M, et al. The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy. Nat Genet. 2000;26:370&#x2013;374. doi: 10.1038/81701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/81701</ArticleId><ArticleId IdType="pubmed">11062483</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. World federation of neurology research group on motor neuron diseases: El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorst J, Chen L, Rosenbohm A, Dreyhaupt J, H&#xfc;bers A, Schuster J, et al. Prognostic factors in ALS: a comparison between Germany and China. J Neurol. 2019;266:1516&#x2013;1525. doi: 10.1007/s00415-019-09290-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09290-4</ArticleId><ArticleId IdType="pubmed">30923935</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan A, Rao MV, Veeranna Nixon RA. Neurofilaments and neurofilament proteins in health and disease. Cold Spring Harb Perspect Biol. 2017;9:a018309. doi: 10.1101/cshperspect.a018309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a018309</ArticleId><ArticleId IdType="pmc">PMC5378049</ArticleId><ArticleId IdType="pubmed">28373358</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura R, Sone J, Atsuta N, Tohnai G, Watanabe H, Yokoi D, et al. Next-generation sequencing of 28 ALS-related genes in a Japanese ALS cohort. Neurobiol Aging. 2016;39(219):e1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">26742954</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiyama A, Niihori T, Warita H, Izumi R, Akiyama T, Kato M, et al. Comprehensive targeted next-generation sequencing in Japanese familial amyotrophic lateral sclerosis. Neurobiol Aging. 2017;53:194.e1&#x2013;194.e8. doi: 10.1016/j.neurobiolaging.2017.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.01.004</ArticleId><ArticleId IdType="pubmed">28160950</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan S, Shatunov A, Sproviero W, Jones AR, Shoai M, Hughes D, et al. A comprehensive analysis of rare genetic variation in amyotrophic lateral sclerosis in the UK. Brain. 2017;140:1611&#x2013;1618. doi: 10.1093/brain/awx082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx082</ArticleId><ArticleId IdType="pmc">PMC5445258</ArticleId><ArticleId IdType="pubmed">28430856</ArticleId></ArticleIdList></Reference><Reference><Citation>Maciel R, Correa R, Bosso Taniguchi J, Prufer Araujo I, Saporta MA. Human tridimensional neuronal cultures for phenotypic drug screening in inherited peripheral neuropathies. Clin Pharmacol Ther. 2020;107:1231&#x2013;1239. doi: 10.1002/cpt.1718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.1718</ArticleId><ArticleId IdType="pubmed">31715019</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal PB, Joshi M, Marinakis NS, Schmitz-Abe K, Ciarlini PD, Sargent JC, et al. Expanding the phenotype associated with the NEFL mutation: neuromuscular disease in a family with overlapping myopathic and neurogenic findings. JAMA Neurol. 2014;71:1413&#x2013;1420. doi: 10.1001/jamaneurol.2014.1432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.1432</ArticleId><ArticleId IdType="pmc">PMC4227917</ArticleId><ArticleId IdType="pubmed">25264603</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavedan C, Buchholtz S, Nussbaum RL, Albin RL, Polymeropoulos MH. A mutation in the human neurofilament M gene in Parkinson's disease that suggests a role for the cytoskeleton in neuronal degeneration. Neurosci Lett. 2002;322:57&#x2013;61. doi: 10.1016/S0304-3940(01)02513-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0304-3940(01)02513-7</ArticleId><ArticleId IdType="pubmed">11958843</ArticleId></ArticleIdList></Reference><Reference><Citation>Wataya T, Nunomura A, Smith MA, Siedlak SL, Harris PL, Shimohama S, et al. High molecular weight neurofilament proteins are physiological substrates of adduction by the lipid peroxidation product hydroxynonenal. J Biol Chem. 2002;277:4644&#x2013;4648. doi: 10.1074/jbc.M110913200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110913200</ArticleId><ArticleId IdType="pubmed">11733539</ArticleId></ArticleIdList></Reference><Reference><Citation>Pecoraro V, Mandrioli J, Carone C, Chi&#xf2; A, Traynor BJ, Trenti T. The NGS technology for the identification of genes associated with the ALS. A systematic review. Eur J Clin Invest. 2020;50(5):e13228. doi: 10.1111/eci.13228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13228</ArticleId><ArticleId IdType="pubmed">32293029</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu ZJ, Lin HX, Wei Q, Zhang QJ, Chen CX, Tao QQ, Liu GL, Ni W, Gitler AD, Li HF, Wu ZY. Genetic spectrum and variability in Chinese patients with amyotrophic lateral sclerosis. Aging Dis. 2019;10(6):1199&#x2013;1206. doi: 10.14336/AD.2019.0215.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2019.0215</ArticleId><ArticleId IdType="pmc">PMC6844596</ArticleId><ArticleId IdType="pubmed">31788332</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W, Xie Y, Zheng M, Lin J, Huang P, Pei Z, Yao X. Clinical and genetic features of patients with amyotrophic lateral sclerosis in southern China. Eur J Neurol. 2020;27(6):1017&#x2013;1022. doi: 10.1111/ene.14213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14213</ArticleId><ArticleId IdType="pubmed">32166880</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>